As health insurance companies pull back on their coverage, R.I. needs to look for ways to buy in bulk and adopt a new health strategy, write doctors at the Rhode Island Public Health Institute.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

JCPenney and Ashley Graham defy the Ozempic trend with a bold, size-inclusive campaign that celebrates curves and drives ...

Wearing a sage-coloured gown and clutching a bouquet of white roses and eucalyptus, Sophie Hinchliffe gazed adoringly at the ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...

According to new survey data from Gallup, for the first time in years, there’s a significant drop in obesity rates. The percentage of obese Americans has apparently dropped from 39.9% in 2022 to 37% ...

Federal layoffs and government shutdown concerns are compounding worker anxieties about employment stability across public ...

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...